Cohen José E, Gomori J Moshe, Itshayek Eyal, Pikis Stylianos, Keigler Galina, Eichel Roni, Leker Ronen R
Department of Neurosurgery, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem 91120, Israel; Department of Radiology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Department of Radiology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
J Clin Neurosci. 2015 Jan;22(1):189-94. doi: 10.1016/j.jocn.2014.09.005. Epub 2014 Nov 28.
Although the procedural and postoperative safety profile of carotid artery stenting (CAS) has been steadily improving, many centers still recommend carotid endarectomy (CEA) over CAS. We assessed outcomes (procedural and postoperative stroke) following tailored CAS in a cohort of patients managed at a single academic medical center. Outcomes for patients with carotid artery stenosis treated from 2005-2013 with CAS were retrospectively reviewed. Stenosis was assessed with Doppler ultrasonography and/or CT angiogram, and angiography. Symptomatic and asymptomatic patients were dichotomized (based on the North American Symptomatic Carotid Endarterectomy Trial [NASCET] and the Asymptomatic Carotid Atherosclerosis Study [ACAS]). CAS technique was chosen based on angiographic and clinical characteristics; procedures were performed with/without pre-angioplasty, cerebral protection, and post-dilation. Endpoints were cumulative incidence of ipsilateral stroke, myocardial infarction, and death within 30 days (primary) or 12 months (secondary). Overall 249 patients (151 men/98 women; mean age 69.9 years) with 254 carotid stenoses were included; 148 lesions (58%) were asymptomatic, and 106 (42%) were symptomatic. CAS was successfully performed in all lesions. At 30 days, ipsilateral transient ischemic attack (TIA)/minor stroke was seen in 6/104 (5.8%) symptomatic patients and no asymptomatic patients; there was no myocardial infarction or ipsilateral major stroke. At 12 months, there was ipsilateral TIA/minor stroke in an additional 3/98 (3.1%) symptomatic and 1/127 (0.8%) asymptomatic patients, and major stroke in 1/98 (1%). The incidence of stroke after CAS compares favorably with rates reported after CEA. The majority of peri-procedural ischemic events following CAS are TIA/minor strokes causing only transient or minor functional impact; major disabling stroke is rare with current techniques.
尽管颈动脉支架置入术(CAS)的手术过程及术后安全性一直在稳步改善,但许多中心仍推荐颈动脉内膜切除术(CEA)而非CAS。我们评估了在一家学术医疗中心接受个体化CAS治疗的一组患者的手术及术后结局(中风情况)。对2005年至2013年接受CAS治疗的颈动脉狭窄患者的结局进行了回顾性分析。通过多普勒超声和/或CT血管造影以及血管造影评估狭窄情况。有症状和无症状患者根据北美症状性颈动脉内膜切除术试验(NASCET)和无症状性颈动脉粥样硬化研究(ACAS)进行二分法分类。根据血管造影和临床特征选择CAS技术;手术在有或无预扩张、脑保护及后扩张的情况下进行。终点指标为30天内(主要终点)或12个月内(次要终点)同侧中风、心肌梗死和死亡的累积发生率。共纳入249例患者(151例男性/98例女性;平均年龄69.9岁),有254处颈动脉狭窄;148处病变(58%)无症状,106处(42%)有症状。所有病变均成功进行了CAS。在30天时,104例有症状患者中有6例(5.8%)出现同侧短暂性脑缺血发作(TIA)/轻度中风,无症状患者中未出现;无心肌梗死或同侧严重中风。在12个月时,另外3例有症状患者(3.1%)和1例无症状患者(0.8%)出现同侧TIA/轻度中风,98例患者中有1例(1%)出现严重中风。CAS术后中风发生率与CEA术后报道的发生率相比更有利。CAS术后大多数围手术期缺血事件为TIA/轻度中风,仅造成短暂或轻微的功能影响;目前技术下严重致残性中风很少见。